Hot Pursuit     26-Oct-20
Aarti Drugs declines over 8% in four days
Aarti Drugs tumbled 4.68% to Rs 713.70, extending losses for fourth consecutive session.

The stock has slumped 8.25% in the four sessions from its recent closing high of Rs 778 recoded on 20 October 2020.

Aarti Drugs announced its September 2020 quarter earnings after market hours on Friday (23 September 2020).

On a consolidated basis, the company's net profit spurted 132.96% to Rs 75.27 crore on 21.07% increase in net sales to Rs 578.11 crore in Q2 September 2020 over Q2 September 2019.

Profit before tax (PBT) stood at Rs 97.12 crore, a 102% jump over Rs 47.87 crore reported in the same period last year. Total tax expense grew 40.5% year on year to Rs 21.85 crore in Q2 September 2020.

The board of the company has recommended an interim dividend of Rs 2.5 per equity share and has fixed 04 November 2020 as the record date for the purpose of payment of interim dividend.

The company's board also passed an enabling resolution for raising upto Rs 350 crore by issuing equity shares or any other instruments or security including fully/partly convertible debentures or by way of a composite issue of non-convertible debentures through qualified institutions placement, private placement/public issue of equity/debt securities or through any other permissible mode.

Aarti Drugs is a pharmaceutical company. The company has a strong presence in the anti-diarrhea, anti-inflammatory therapeutic groups.

Previous News
  Aarti Drugs consolidated net profit declines 3.94% in the June 2019 quarter
 ( Results - Announcements 26-Jul-19   16:29 )
  Volumes spurt at Aarti Drugs Ltd counter
 ( Hot Pursuit - 24-Jul-23   14:30 )
  Aarti Drugs consolidated net profit rises 11.51% in the March 2017 quarter
 ( Results - Announcements 23-May-17   17:50 )
  Aarti Drugs standalone net profit rises 60.66% in the December 2014 quarter
 ( Results - Announcements 30-Jan-15   16:54 )
  Aarti Drugs sizzles after Tarapur facility gets EIR from USFDA
 ( Hot Pursuit - 24-Dec-24   15:48 )
  Aarti Drugs soars on share buyback proposal
 ( Hot Pursuit - 22-Aug-24   11:17 )
  Aarti Drugs to consider buyback
 ( Corporate News - 22-Aug-24   10:50 )
  Aarti Drugs consolidated net profit rises 114.50% in the March 2020 quarter
 ( Results - Announcements 15-May-20   15:06 )
  Aarti Drugs consolidated net profit rises 105.36% in the June 2018 quarter
 ( Results - Announcements 14-Aug-18   15:15 )
  Aarti Drugs standalone net profit rises 19.58% in the March 2017 quarter
 ( Results - Announcements 23-May-17   17:50 )
  Aarti Drugs net profit rises 58.94% in the March 2014 quarter
 ( Results - Announcements 03-May-14   17:03 )
Other Stories
  BLS Intl Q3 PAT climbs 47% YoY to Rs 128 cr in FY25
  11-Feb-25   15:49
  Prince Pipes slumps after reporting dismal Q3 results
  11-Feb-25   15:30
  Crisil jumps after Q4 PAT rises 6.9% YoY
  11-Feb-25   15:24
  Northern Spirits spurts after Q3 PAT zooms 110% YoY to Rs 9 crore
  11-Feb-25   15:14
  Keystone Realtors Q3 PAT rises to Rs 30 cr in FY25
  11-Feb-25   15:10
  Talbros Automotive Q3 PAT rises 5% YoY to Rs 24 cr
  11-Feb-25   15:03
  HBL Engineering Ltd leads losers in 'A' group
  11-Feb-25   15:00
  Welspun Investments & Commercials Ltd leads losers in 'B' group
  11-Feb-25   14:45
  Volumes soar at CRISIL Ltd counter
  11-Feb-25   14:30
  Cera Sanitaryware declines as Q3 PAT slips 10% YoY to Rs 46 cr
  11-Feb-25   14:30
Back Top